Biogen Inc. Stock
Price
Target price
€110.30
€110.30
0.500%
0.55
0.500%
€247.17
20.06.25 / Tradegate
WKN: 789617 / Symbol: BIIB / Name: Biogen / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Biogen Inc. is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Biogen
sharewise wants to provide you with the best news and tools for Biogen, so we directly link to the best financial data sources.
Financials
News
Biogen Stock Is Mutating Into a Value Play
Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from those highs to 12-year lows at $137.33. The medical sector biotechnology
Biogen Stock: Mixed Q4 Results Spark Strategic Shift
Biogen's fourth quarter 2024 performance presents a complex picture for investors, with revenue climbing 2.9% to $2.46 billion and adjusted earnings per share reaching $3.44, surpassing market
Biogen (BIIB) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Biogen (NASDAQ: BIIB)Q4 2024 Earnings CallFeb 12, 2025, 8:30 a.m. ET
Operator
Source Fool.com
